Biotech Specialty Pharma

Immunome, Inc.

c/o LIMR, Room 222
Wynnewood, PA 19096 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Provides unbiased immune response method to combat infectious disease, neurological, cancer, and autoimmune diseases.

Management Timothy Pelura, CEO; Scott Dessain, Chief Scientific Officer; George Hobbs, SVP Corporate Development and General Counsel

Click here for Financial Data
Keywords: infectious disease, immune, cancer, biodefense, neurological, vaccine


Updated: Sept. 12, 2014


Immunome is a discovery stage biopharmaceutical company that has created a proprietary Native Human Monoclonal Antibody (N-huMAB) platform. N-huMAbs are in the exact structures created by nature and ......view more

Products / Services

Native human antibodies for therapy and diagnosis.......view more

Technology / Differentiation

Human hybridoma platform for native human antibody isolation....view more


Clinical development through POC studies and multiple partnerships/collaborations on proprietary targets to generate non-dilutive capital....view more

Revenue / Funding

$1.9M in angel and grants to date. Currently raising $650K remainder of seed financing. Partnership dollars are supporting internal cancer program....view more


Preclinical stage....view more